278.43
Schlusskurs vom Vortag:
$271.13
Offen:
$266.93
24-Stunden-Volumen:
138.59K
Relative Volume:
0.31
Marktkapitalisierung:
$10.44B
Einnahmen:
$1.16B
Nettoeinkommen (Verlust:
$34.55M
KGV:
323.76
EPS:
0.86
Netto-Cashflow:
$134.18M
1W Leistung:
+1.16%
1M Leistung:
-2.49%
6M Leistung:
+44.20%
1J Leistung:
+31.60%
Penumbra Inc Stock (PEN) Company Profile
Firmenname
Penumbra Inc
Sektor
Branche
Telefon
(510) 995-2486
Adresse
ONE PENUMBRA PLACE, ALAMEDA, CA
Vergleichen Sie PEN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
PEN
Penumbra Inc
|
278.52 | 10.44B | 1.16B | 34.55M | 134.18M | 0.86 |
![]()
ABT
Abbott Laboratories
|
131.65 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
100.86 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
375.54 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
88.65 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
72.20 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-14 | Eingeleitet | BofA Securities | Buy |
2025-01-21 | Eingeleitet | UBS | Buy |
2024-12-17 | Eingeleitet | Oppenheimer | Outperform |
2024-12-11 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2024-09-18 | Eingeleitet | Stifel | Buy |
2024-09-03 | Eingeleitet | Leerink Partners | Outperform |
2024-07-31 | Herabstufung | Citigroup | Buy → Neutral |
2024-07-31 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2024-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
2023-09-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
2023-03-29 | Herabstufung | Needham | Buy → Hold |
2023-01-30 | Eingeleitet | Piper Sandler | Overweight |
2022-11-04 | Hochstufung | Citigroup | Neutral → Buy |
2022-10-12 | Eingeleitet | Jefferies | Buy |
2022-10-05 | Herabstufung | Citigroup | Buy → Neutral |
2022-09-09 | Hochstufung | Needham | Hold → Buy |
2022-07-18 | Eingeleitet | RBC Capital Mkts | Outperform |
2022-04-19 | Eingeleitet | Deutsche Bank | Buy |
2022-03-08 | Eingeleitet | Needham | Hold |
2021-09-16 | Eingeleitet | Truist | Buy |
2021-06-04 | Hochstufung | BTIG Research | Neutral → Buy |
2020-12-16 | Herabstufung | BTIG Research | Buy → Neutral |
2020-10-07 | Fortgesetzt | Canaccord Genuity | Buy |
2020-09-29 | Eingeleitet | BTIG Research | Buy |
2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
2020-03-05 | Eingeleitet | Citigroup | Buy |
2019-06-13 | Bestätigt | BofA/Merrill | Buy |
2019-05-30 | Hochstufung | JP Morgan | Neutral → Overweight |
2019-05-21 | Eingeleitet | William Blair | Outperform |
2018-10-29 | Fortgesetzt | BofA/Merrill | Buy |
2018-10-08 | Eingeleitet | RBC Capital Mkts | Outperform |
2018-02-21 | Eingeleitet | William Blair | Outperform |
2018-01-02 | Herabstufung | JP Morgan | Overweight → Neutral |
2015-11-30 | Bestätigt | Canaccord Genuity | Buy |
2015-10-13 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Penumbra Inc Aktie (PEN) Neueste Nachrichten
Breakthrough Clinical Data: Penumbra's CAVT Slashes Hospital Stays by 46%, Achieves 99% Success Rate - Stock Titan
Meiji Yasuda Asset Management Co Ltd. Buys New Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat
ROSEN, A LEADING LAW FIRM, Encourages Penumbra, Inc. Investors to Secure Counsel Before Important March 16 DeadlinePEN - PR Newswire
Penumbra Insider Sold Shares Worth $3,405,253, According to a Recent SEC Filing - MarketScreener
Penumbra director Arani sells $3.41 million in stock - Investing.com India
Thrombectomy Devices Market Surge: Key Players & Future Outlook - openPR.com
New Thrombectomy Product Launches Support PEN Stock Amid Macro Issues - MSN
Penumbra CEO Adam Elsesser sells $4.59 million in stock By Investing.com - Investing.com Australia
Penumbra CEO Adam Elsesser sells $4.59 million in stock - Investing.com
Do Its Financials Have Any Role To Play In Driving Penumbra, Inc.'s (NYSE:PEN) Stock Up Recently? - Yahoo Finance
Has Penumbra, Inc.'s (NYSE:PEN) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - simplywall.st
Penumbra (PEN) Down 8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Peering Into Penumbra's Recent Short Interest - Benzinga
B of A Securities Initiates Coverage of Penumbra (BMV:PEN) with Buy Recommendation - Nasdaq
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Penumbra, Inc. Investors of Important Deadline in Securities Class Action – PEN - Business Wire
Penumbra Inc (PEN) Trading 4.6% Higher on Mar 17 - GuruFocus.com
Penumbra Inc (PEN) Shares Up 4.6% on Mar 15 - GuruFocus.com
Penumbra launched at BofA with Buy on a broad rollout of Flash 2.0 - MSN
What Analysts Are Saying About Penumbra Stock - Benzinga
Penumbra stock launched at BofA with Buy (PEN:NYSE) - Seeking Alpha
B of A Securities Initiates Coverage of Penumbra (PEN) with Buy Recommendation - Nasdaq
Penumbra initiated with a Buy at BofA - TipRanks
Penumbra, Inc. (NYSE:PEN) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World
Penumbra, Inc. (NYSE:PEN) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Penumbra Off And Running On Renewed Enthusiasm For Mechanical Thrombectomy - Seeking Alpha
Adam Elsesser Sells 61,600 Shares of Penumbra, Inc. (NYSE:PEN) Stock - Defense World
Johanna Roberts Sells 600 Shares of Penumbra, Inc. (NYSE:PEN) Stock - MarketBeat
Penumbra CEO Adam Elsesser sells $17.47 million in stock By Investing.com - Investing.com Canada
Penumbra CEO Adam Elsesser sells $17.47 million in stock - Investing.com
Penumbra director O’Rourke sells $14,274 in stock By Investing.com - Investing.com South Africa
Penumbra director Arani sells $3.45 million in stock By Investing.com - Investing.com South Africa
Penumbra’s Growth Potential Balanced by Market Uncertainties: A Hold Recommendation - TipRanks
Insider Sell: Bridget O'Rourke Sells Shares of Penumbra Inc (PEN) - GuruFocus
Penumbra, Inc. to Host Earnings Call - ACCESS Newswire
Insider Sell: Arani Bose Sells 12,000 Shares of Penumbra Inc (PE - GuruFocus.com
Penumbra director O’Rourke sells $14,274 in stock - Investing.com India
Penumbra EVP Johanna Roberts sells shares worth $172,458 - Investing.com India
Penumbra EVP Johanna Roberts sells shares worth $172,458 By Investing.com - Investing.com South Africa
Penumbra’s chief accounting officer sells shares worth over $2.2 million - Investing.com
Penumbra CFO Maggie Yuen sells $571,994 in stock - Investing.com
Penumbra director Arani sells $3.45 million in stock - Investing.com
Penumbra Announces Board Transition with Kassing’s Retirement - TipRanks
Aspiration-first approaches gather further traction thanks to ‘game-changing’ thrombectomy technologies - NeuroNews International
Penumbra Inc.: Will Its Market Penetration & Access Initiatives Help Capture The Thrombectomy Market? - Smartkarma
Finanzdaten der Penumbra Inc-Aktie (PEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):